SEED THERAPEUTICS Trademark

Trademark Overview


On Wednesday, August 27, 2025, a trademark application was filed for SEED THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the SEED THERAPEUTICS trademark a serial number of 99361665. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, August 27, 2025. This trademark is owned by SEED Therapeutics US, Inc.. The SEED THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

drug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protei...
seed therapeutics

General Information


Serial Number99361665
Word MarkSEED THERAPEUTICS
Filing DateWednesday, August 27, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, August 27, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the literal term SEED THERAPEUTICS with SEED in block letters and the second E backwards, and positioned above THERAPEUTICS, with a split hexagon positioned above the term SEED.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and Servicesdrug discovery, development and validation services; pharmaceutical research and development; providing medical research and scientific information in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; providing scientific, pharmaceutical, clinical and medical research information via the internet; consulting services in the fields of pharmaceuticals, biology, chemistry, biochemistry, biotechnology, and clinical trials; research and development of new products; scientific, medical and clinical research and development services; providing information, scientific, pharmaceutical, clinical, and medical research, drug discovery, development and validation, and consulting services with respect to identifying ubiquitin ligases; providing information, scientific, pharmaceutical, clinical and medical research, drug discovery, development and validation, and consulting services with respect to using a photocatalyst molecule for labeling a protein proximate to a target disease-causing protein within a live cell

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 27, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSEED Therapeutics US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKing of Prussia, PA 19406

Trademark Events


Event DateEvent Description
Wednesday, August 27, 2025NEW APPLICATION ENTERED
Wednesday, August 27, 2025APPLICATION FILING RECEIPT MAILED